Endocrine Today

The content you need, when you need it.

[Endocrine Today @EndocrineToday]

💡 The monoclonal antibody burosumab-twza induces greater improvements in patient-reported outcomes than conventional therapy in X-linked hypophosphatemia, including

📌 pain
📌 physical function
📌 stiffness

https://t.co/Mt0sfVpBPP

[Cardiology Today @CardiologyToday]

🔎 Stage A of HF corresponds to stage 2 of CKM syndrome, stage B of HF corresponds to stage 3 of CKM syndrome and stages C and D of HF correspond to stage 4 of CKM syndrome, a speaker said at #CMHC2026.

@CMHC_CME @EndocrineToday @GoHealio

https://t.co/yfNupMDv82

[Cardiology Today @CardiologyToday]

✔️Sleep quality affects cardiometabolic health in many ways, and it is important for healthcare professionals to routinely ask their patients about it, according to a speaker at #CMHC2026.

@CMHC_CME @EndocrineToday @GoHealio @HealioPulm @BrighamWomens

https://t.co/4Fu45nHEic

[Endocrine Today @EndocrineToday]

📈 Two measures of glycemic variability increased at 3 months for adults with type 1 #diabetes after they stopped receiving #Ozempic, researchers found in the ADJUST-T1D extension study.

@BreakthroughT1D @IUMedSchool @GoHealio

https://t.co/CGvchw0dXI

[Endocrine Today @EndocrineToday]

🦴 Burosumab-twza confers a greater increase in serum phosphate plus larger improvements in patient-reported outcomes compared with conventional therapy for adults with X-linked hypophosphatemia, according to real-world data published in @The_JBMR.

https://t.co/e8kVZY09SW

[Endocrine Today @EndocrineToday]

One question can lead to so much more. Explore related questions, create patient handouts and personalize your Healio AI experience with every interaction.👉 https://t.co/zmuRoJBRjX

#HealioAI #ClinicalAI

[Healio @GoHealio]

🧠🌫️ #ADHD drugs may help improve menopausal brain fog among biological midlife women.

Read more:
https://t.co/YrhgertCV0

[Healio @GoHealio]

⚠️ HHS announced President Donald Trump signed an executive order establishing a new women’s health division in NIH within 90 days.

Read more here:
https://t.co/dLKlD5GOzD

[Healio @GoHealio]

🛴🏥 Trauma admissions for e-scooter injuries nearly doubled from 2021 to 2023 — and only 12% of patients wore a helmet.

Serious injuries were also disproportionately associated with younger age.
https://t.co/LocDApLr3d

[Cardiology Today @CardiologyToday]

BREAKING

A cardiologist at @BIDMChealth breaks down the events that likely led to Philadelphia @Eagles Jalen Hurts’ diagnosis with DVT and bilateral pulmonary embolisms. Read more: https://t.co/9U2nmCo0jJ

@GoHealio #sportscardiology

[Cardiology Today @CardiologyToday]

🔔The stages of heart failure correspond with the stages of cardio-kidney-metabolic (CKM) syndrome and prevention of HF should in part be based on prevention of CKM syndrome comorbidities, @BiykemB said at #CMHC2026.

@CMHC_CME @EndocrineToday @GoHealio

https://t.co/8K8o8JGAbS

[Endocrine Today @EndocrineToday]

🗣️ “When there are medical students and residents who are exposed to the field, they are loving the experience.”

Hear more from Dr. Tandy Aye of @StanfordMed as she discusses her talk on the pediatric endocrinologist shortage

@BreakthroughT1D @GoHealio

https://t.co/nXtdSUSUrG

[Endocrine Today @EndocrineToday]

💉 Adults with type 1 #diabetes had a significant decline in time in range 3 months after they discontinued semaglutide therapy.

Learn more about the ADJUST-T1D extension study 👇

@BreakthroughT1D @IUMedSchool @GoHealio

https://t.co/Qv8saXJZW9

[Ocular Surgery News @Healio_OSN]

‼️New on @GoHealio‼️

A phase 2 clinical trial investigating EC-104, a fluocinolone acetonide extended-release intravitreal implant for #DiabeticMacularEdema, met its primary endpoint.

Read more: 🔗

https://t.co/0i1i7K8WDa

[Endocrine Today @EndocrineToday]

🚨 The rules are simple: No Google, no ChatGPT, no Claude. Just you vs. WORD DOC. Think you can solve it?

Play now: https://t.co/FCmWcrnv01

#WordChallenge #WORDDOC

[Cardiology Today @CardiologyToday]

🗣️ “You can do things to at least delay the onset [of dementia]. And that’s very powerful as a clinical tool,” Rachel Whitmer, PhD, said at #CMHC2026.

@CMHC_CME @EndocrineToday @GoHealio @healioneurology @HealioPsych

https://t.co/Gq1av5joqk

[Cardiology Today @CardiologyToday]

HOT OFF THE PRESS

Read our #HealioExclusive on how physicians and turn patients’ questions about online misinformation into an opportunity to build trust and educate.

https://t.co/PP7Q5Q3QQc

@GoHealio @EndocrineToday @HMethodistCV @CleClinicHVTI @DCRINews

[Endocrine Today @EndocrineToday]

♀️ The generic version of Climara Pro, which was recently approved by the @US_FDA, is indicated for the treatment of moderate to severe vasomotor symptoms during #menopause and for prevention of postmenopausal osteoporosis.

@ZydusUniverse @healiowomen

https://t.co/FZezLJxs7g

[Endocrine Today @EndocrineToday]

🎥 Don’t miss this @GoHealio exclusive interview with Dr. Tandy Aye of @StanfordMed at @BreakthroughT1D Clinical and Research Congress.

Dr. Aye discusses the pediatric endocrinologist shortage in the U.S. and what can be done about it.

https://t.co/nGkrG6qt6n

[Nephrology News & Issues @Nephronline]

Together with community organizations and local nonprofits, @DaVitaDoc conducts neighborhood events to screen for hypertension, diabetes and #kidneydisease.

Here’s what they’ve learned 👇
https://t.co/iuQDvlMdaA